$TuHURA Biosciences (HURA.US)$ 亲爱的朋友们，这只股票的趋势正在朝着1美元走，因为涉及未来融资，所以股票价格越低越好。图胡拉的股东们根本不在意股价，因为你可以想象到他们的成本有多低。就像我今早提到的那样，购买与特朗普相关的股票是一个不错的选择。
已翻译
5
1
![[强]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "强"){kind=small}
$TuHURA生物科技（HURA.US）$ 我的股票代码仍然是KTRA，还没有改成HURA。证券公司说这是系统问题。我对这种情况非常担忧，他们甚至不知道系统何时能完成转换。
已翻译
1
$TuHURA Biosciences (HURA.US)$ 2024年5月6日，Laurel Lee从TuHURA生物科技公司购买了可转债。目前尚不清楚她是否仍然持有。这支股票很奇怪，在F10中几乎没有任何信息。
已翻译
1
$TuHURA Biosciences (HURA.US)$ 有谁知道我的券商为什么还没有更改股票的逐笔明细？而且我的账户中的股票仍然保持不变，仍然显示为KTRA
已翻译
1
6
$Kintara Therapeutics (KTRA.US)$ After the 1:40 reverse stock split, Kintara has 1,384,250 shares, with a price of $74 per share. tuhura issued an additional 13.6 million shares, but these new shares were not given to Kintara shareholders. The 1,384,250 shares represent 2.85% of the total shares after the merger. TuHURA issued a total of 48,570,175 shares, and the stock price dropped to $2.11 due to dilution. Even though Kintara shareholders own 2.85% of...
5
$kintara therapeutics (KTRA.US)$ 公司的股东以2400万票赞成对600万票反对通过了与合并的提案。现在只有一些后勤问题需要解决，以确保有足够的选票。他们将于10天后举行会议。由于这是$ktra前进的唯一途径，双方董事会和管理团队都希望这项合并能成功。只是许多小股东尚未投票。
如果出售行为是因为合并未能顺利进行而导致的...
如果出售行为是因为合并未能顺利进行而导致的...
已翻译
5
3
$Kintara Therapeutics (KTRA.US)$ $KTRA is merging with TUHURA, which will be a multi-billion dollar company. The pipeline is in collaboration with Keytruda, which is 25b. FTDs can never be settled by merger date.
1
$kintara therapeutics (ktra.us)$ 我不确定这里有多少股东，但我仍然看跌一种投票方式
写封电子邮件给ksferlazza@allianceadvisorsllc.com，然后她会让你提供一些证据证明你是ktra的股东。
一旦她确认，您将收到用于投票的用户名和密码。
写封电子邮件给ksferlazza@allianceadvisorsllc.com，然后她会让你提供一些证据证明你是ktra的股东。
一旦她确认，您将收到用于投票的用户名和密码。
已翻译
3
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)